Biogen hopes for breakthrough at Danish Medicines Council after new price drop: "We have taken significant action"

The Danish Medicines Council, which decides whether new medicines should be accepted for widespread use at Danish hospitals, will decide whether to expand the use of Spinraza (nusinersen) to more patients at a video meeting on May 13, the council reports.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app